The Drugs for Neglected Diseases Initiative has announced a new HIV drug pediatric formulation offered by the manufacturer for $1 a day. Where else are vaccines and biologics changing lives?
Want to dig deeper into vaccines and biologics?
-
Article
Providing Regulatory Clarity for Cell- and Gene-based Therapies
Read Now
Adam Istas
Journal for Clinical Studies -
Podcast
Landmark AMA to Rely on Regulatory Reliance
Listen Now
David Mukanga -
Article
South Korea MFDS: Improving Regulatory Science Based on R&D
Read Now
In-Sook Park
Global Forum -
Article
African Medicines Agency Treaty Ratification, Regional Regulatory Harmonization, and Joint Assessments Actively Under Way
Read Now
David Mukanga
Global Forum -
Article
Clinical Development of Biologics Approved by the US FDA 2003-2016
Read Now
G. Caleb Alexander et al.
Therapeutic Innovation & Regulatory Science
Member-only content
-
Article
Giving Diseases a Gut Punch: Microbiome Applications in Clinical Trials
Read Now
Kinari Shah
Journal for Clinical Studies
Want to learn more?
To learn more about the clinical development and regulatory approval of vaccines and biologics, join our DIA Biostatistics Industry and Regulator Forum.